481 institutes (response rate; 26.4%). There were 51 institutes with the patients who were diagnosed as PCD. Overall, 116 cases were reported as patients with PCD and total 73 patients were followed by the institutes at the time of this survey. The diagnostic methods are transmission electron microscopy (76 cases), high-speed video analysis (17 cases), nasal nitric oxide measurement (16 cases), and others (24 cases). The numbers of the patients diagnosed by genetic analysis were 11 cases.
Conclusion: This first nation-wide survey of PCD in Japan provided the basis for further analysis of clinical characteristics in patients with PCD by the second survey and establishment of appropriate diagnosis criteria in Japan. The Philippine Heart Center, Philippines Background and Aims: Nitric oxide is a biological mediator produced by the human lung and is present in the exhaled breath. This agent is implicated in the pathophysiology of lung diseases. Existing studies already established FeNO as a biomarker of airway inflammation, especially in asthma. It is therefore essential to define the normal values among healthy children and compared it with those with respiratory symptoms as occurred in upper respiratory tract infection (URTI) and bronchial asthma. It is also equally important to determine any factors that affect the levels of FeNO.
Methods:
The study was conducted among grade school children in a public school. Parents were asked to answer questionnaires for presence of probable asthma and URTI. The children were categorized into three: healthy, URTI, and asthma groups. FeNO levels were measured among subjects.
Results:
The median FeNO level of the study population is 12.0 ppb (11.6 -21.3 ppb). The median FeNO level among healthy subjects is 9.6 ppb (6.0-15.3 ppb). For those with URTI and asthma, the median FeNO levels are 12.6 ppb (9.3-35 ppb) and 31.8 (15.3-62.15 ppb) respectively. The levels of the asthma group were significantly higher than the healthy children with a P value of 0.0488 . There was no significant difference in the FeNO levels between the asthma and the URTI group. Body mass index, weight and height do not alter FeNO measurement.
However, FeNO levels of the males and the younger age group (6-11 years old) are significantly higher with P values of 0.0337 and 0.0061 respectively. empirical antibiotic treatment right after cultures being collected. If pathogens are identified, the antibiotic treatment may be adjusted to a definite treatment accordingly. Theoretically, patients whose causal pathogens are identified will receive more appropriate definitive antibiotic treatments thus may have a better outcome. The aim of this study was to investigate whether pathogen identification influences clinical outcomes in critically ill patients with pneumonia.
Conclusion
Methods: We conducted a retrospective observational cohort study of pneumonia patients admitted to the medical intensive care unit (MICU) in a tertiary hospital from January 2012 to October 2013. Clinical information and culture reports were collected. We set ICU mortality as the primary outcome.
Results: A total of 665 patients with pneumonia were enrolled in this study, and 232 (34.9%) patients died in the ICU. Pathogens were identified in 260 patients (39.1%), with Gram-negative bacteria in 71% of patients, Gram-positive bacteria in 15%, and polymicrobial infection in 14%. Klebsiella pneumoniae (67, 25.8%) was the most commonly identified pathogen, followed by Pseudomonas aeruginosa (57, 21.9%), and Acinotobacter baumannii (41, 15.8%). Patients without pathogens identified had similar mortality rate compared to patients with pathogens identified (33.6% vs 33.9%, P = 0.405; adjusted OR = 0.97, 95% CI = 0.68-1.38, P = 0.845). However, we found a trend that hospitalacquired pneumonia (HAP) patients without pathogen identified had higher mortality rate than those with pathogen identified (48.9% vs 34.9%, P = 0.053), while community-acquired pneumonia (CAP) patients without pathogen identified had lower mortality rate than those with pathogen identified (22.7% vs 37.9%, P = 0.014).
Conclusion:
Pathogen identification was not associated with mortality in critically ill patients with pneumonia. However, we found a trend that pathogen identification may be associated with a lower mortality in HAP and a higher mortality in CAP. 
